Annual Operating Profit
-$18.01 M
-$2.75 M-18.06%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual operating income is -$18.01 million, with the most recent change of -$2.75 million (-18.06%) on December 1, 2023.
- During the last 3 years, CSCI annual operating profit has fallen by -$11.94 million (-196.97%).
- CSCI annual operating profit is now -282.97% below its all-time high of $9.84 million, reached on December 1, 2018.
Performance
CSCI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$4.83 M
-$1.08 M-28.74%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly operating income is -$4.83 million, with the most recent change of -$1.08 million (-28.74%) on September 1, 2024.
- Over the past year, CSCI quarterly operating profit has dropped by -$2.71 million (-127.77%).
- CSCI quarterly operating profit is now -333.47% below its all-time high of $2.07 million, reached on March 1, 2022.
Performance
CSCI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$12.52 M
-$3.72 M-42.30%
September 1, 2024
Summary
- As of February 6, 2025, CSCI TTM operating income is -$12.52 million, with the most recent change of -$3.72 million (-42.30%) on September 1, 2024.
- Over the past year, CSCI TTM operating profit has dropped by -$7.81 million (-165.60%).
- CSCI TTM operating profit is now -326.31% below its all-time high of $5.53 million, reached on June 1, 2016.
Performance
CSCI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CSCI Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.1% | -127.8% | -165.6% |
| 3 y3 years | -197.0% | -127.8% | -165.6% |
| 5 y5 years | -283.0% | -127.8% | -165.6% |
CSCI Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.7% | at low | -333.5% | at low | -334.6% | at low |
| 5 y | 5-year | -197.0% | at low | -333.5% | at low | -334.6% | at low |
| alltime | all time | -283.0% | +71.1% | -333.5% | at low | -326.3% | at low |
COSCIENS Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.83 M(+28.7%) | -$12.52 M(+42.3%) |
| Jun 2024 | - | -$3.75 M(+107.2%) | -$8.80 M(+42.9%) |
| Mar 2024 | - | -$1.81 M(-14.6%) | -$6.16 M(+30.6%) |
| Dec 2023 | -$18.01 M(+18.1%) | -$2.12 M(+91.0%) | -$4.72 M(+66.3%) |
| Sep 2023 | - | -$1.11 M(-0.3%) | -$2.83 M(+204.2%) |
| Jun 2023 | - | -$1.11 M(+202.9%) | -$931.80 K(-149.2%) |
| Mar 2023 | - | -$367.80 K(+51.9%) | $1.89 M(-56.3%) |
| Dec 2022 | -$15.25 M(+75.9%) | -$242.10 K(-130.6%) | $4.33 M(-18.9%) |
| Sep 2022 | - | $792.10 K(-53.7%) | $5.34 M(+3.6%) |
| Jun 2022 | - | $1.71 M(-17.4%) | $5.15 M(+25.1%) |
| Mar 2022 | - | $2.07 M(+170.9%) | $4.12 M(+57.5%) |
| Dec 2021 | -$8.67 M(+43.0%) | $764.30 K(+25.9%) | $2.62 M(+53.1%) |
| Sep 2021 | - | $607.30 K(-10.2%) | $1.71 M(+23.4%) |
| Jun 2021 | - | $676.50 K(+19.3%) | $1.38 M(-17.3%) |
| Mar 2021 | - | $566.90 K(-496.4%) | $1.67 M(-6.0%) |
| Dec 2020 | -$6.06 M(-36.5%) | -$143.00 K(-150.5%) | $1.78 M(-17.9%) |
| Sep 2020 | - | $283.10 K(-70.7%) | $2.17 M(+17.3%) |
| Jun 2020 | - | $966.10 K(+43.3%) | $1.85 M(+190.2%) |
| Mar 2020 | - | $674.30 K(+173.5%) | $637.70 K(-355.4%) |
| Dec 2019 | -$9.54 M(-197.0%) | $246.50 K(-780.9%) | -$249.70 K(-264.1%) |
| Sep 2019 | - | -$36.20 K(-85.3%) | $152.20 K(-14.4%) |
| Jun 2019 | - | -$246.90 K(+15.9%) | $177.90 K(-64.3%) |
| Mar 2019 | - | -$213.10 K(-132.9%) | $498.50 K(-29.8%) |
| Dec 2018 | $9.84 M(-142.7%) | $648.40 K(-6275.2%) | $710.60 K(-161.2%) |
| Sep 2018 | - | -$10.50 K(-114.2%) | -$1.16 M(+149.9%) |
| Jun 2018 | - | $73.70 K(-7470.0%) | -$464.30 K(-285.3%) |
| Mar 2018 | - | -$1000.00(-99.9%) | $250.50 K(-45.0%) |
| Dec 2017 | -$23.07 M(-21.7%) | -$1.22 M(-278.3%) | $455.10 K(-77.5%) |
| Sep 2017 | - | $685.70 K(-13.0%) | $2.02 M(-7.0%) |
| Jun 2017 | - | $788.50 K(+287.3%) | $2.17 M(-33.2%) |
| Mar 2017 | - | $203.60 K(-40.2%) | $3.25 M(-27.6%) |
| Dec 2016 | -$29.48 M(-15.5%) | $340.70 K(-59.3%) | $4.48 M(-17.9%) |
| Sep 2016 | - | $836.50 K(-55.2%) | $5.46 M(-1.3%) |
| Jun 2016 | - | $1.87 M(+29.5%) | $5.53 M(+26.4%) |
| Mar 2016 | - | $1.44 M(+9.3%) | $4.38 M(+54.0%) |
| Dec 2015 | -$34.88 M(-6.7%) | $1.32 M(+45.2%) | $2.84 M(+75.6%) |
| Sep 2015 | - | $908.30 K(+28.2%) | $1.62 M(+13.6%) |
| Jun 2015 | - | $708.60 K(-855.4%) | $1.42 M(-2.0%) |
| Mar 2015 | - | -$93.80 K(-198.8%) | $1.45 M(-24.3%) |
| Dec 2014 | -$37.40 M(+36.1%) | $94.90 K(-86.7%) | $1.92 M(+5.6%) |
| Sep 2014 | - | $715.00 K(-3.1%) | $1.82 M(+36.0%) |
| Jun 2014 | - | $738.00 K(+98.0%) | $1.34 M(+181.7%) |
| Mar 2014 | - | $372.80 K(-5206.8%) | $474.60 K(-13.3%) |
| Dec 2013 | -$27.48 M(-7.6%) | -$7300.00(-103.1%) | $547.30 K(+62.6%) |
| Sep 2013 | - | $233.30 K(-287.8%) | $336.50 K(+2158.4%) |
| Jun 2013 | - | -$124.20 K(-127.9%) | $14.90 K(+473.1%) |
| Mar 2013 | - | $445.50 K(-304.3%) | $2600.00(-100.7%) |
| Dec 2012 | -$29.74 M(-6.2%) | -$218.10 K(+147.0%) | -$399.80 K(-548.2%) |
| Sep 2012 | - | -$88.30 K(-35.3%) | $89.20 K(-27.9%) |
| Jun 2012 | - | -$136.50 K(-416.7%) | $123.70 K(-70.4%) |
| Mar 2012 | - | $43.10 K(-84.1%) | $418.60 K(-46.8%) |
| Dec 2011 | -$31.71 M(+27.8%) | $270.90 K(-603.5%) | $786.60 K(+2.4%) |
| Sep 2011 | - | -$53.80 K(-134.0%) | $768.40 K(-20.5%) |
| Jun 2011 | - | $158.40 K(-61.5%) | $966.90 K(+21.4%) |
| Mar 2011 | - | $411.10 K(+62.7%) | $796.50 K(+102.1%) |
| Dec 2010 | -$24.81 M | $252.70 K(+74.6%) | $394.10 K(-256.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $144.70 K(-1305.8%) | -$251.80 K(-1.3%) |
| Jun 2010 | - | -$12.00 K(-237.9%) | -$255.20 K(+530.1%) |
| Mar 2010 | - | $8700.00(-102.2%) | -$40.50 K(-126.8%) |
| Dec 2009 | -$23.96 M(-61.6%) | -$393.20 K(-378.3%) | $151.10 K(-70.1%) |
| Sep 2009 | - | $141.30 K(-30.3%) | $504.70 K(-2623.5%) |
| Jun 2009 | - | $202.70 K(+1.2%) | -$20.00 K(-96.3%) |
| Mar 2009 | - | $200.30 K(-605.8%) | -$535.70 K(-53.9%) |
| Dec 2008 | -$62.38 M(+79.5%) | -$39.60 K(-89.7%) | -$1.16 M(-16.6%) |
| Sep 2008 | - | -$383.40 K(+22.5%) | -$1.39 M(+2.0%) |
| Jun 2008 | - | -$313.00 K(-26.4%) | -$1.37 M(+30.7%) |
| Mar 2008 | - | -$425.00 K(+56.7%) | -$1.04 M(+95.5%) |
| Dec 2007 | -$34.75 M(+44.2%) | -$271.30 K(-23.9%) | -$534.30 K(-15.3%) |
| Sep 2007 | - | -$356.30 K(-4610.1%) | -$630.90 K(+125.4%) |
| Jun 2007 | - | $7900.00(-90.7%) | -$279.90 K(+51.3%) |
| Mar 2007 | - | $85.40 K(-123.2%) | -$185.00 K(-27.2%) |
| Dec 2006 | -$24.11 M(+151.6%) | -$367.90 K(+6841.5%) | -$254.20 K(-191.7%) |
| Sep 2006 | - | -$5300.00(-105.2%) | $277.20 K(+6.5%) |
| Jun 2006 | - | $102.80 K(+534.6%) | $260.40 K(+31.4%) |
| Mar 2006 | - | $16.20 K(-90.1%) | $198.10 K(+410.6%) |
| Dec 2005 | -$9.58 M(+39.3%) | $163.50 K(-839.8%) | $38.80 K(-112.8%) |
| Sep 2005 | - | -$22.10 K(-154.6%) | -$303.90 K(-40.0%) |
| Jun 2005 | - | $40.50 K(-128.3%) | -$506.90 K(-17.7%) |
| Mar 2005 | - | -$143.10 K(-20.1%) | -$615.60 K(+22.9%) |
| Dec 2004 | -$6.88 M(-31.7%) | -$179.20 K(-20.4%) | -$500.80 K(+56.9%) |
| Sep 2004 | - | -$225.10 K(+230.1%) | -$319.20 K(+68.9%) |
| Jun 2004 | - | -$68.20 K(+141.0%) | -$189.00 K(+177.1%) |
| Mar 2004 | - | -$28.30 K(-1279.2%) | -$68.20 K(-36.6%) |
| Dec 2003 | -$10.08 M(-22.9%) | $2400.00(-102.5%) | -$107.60 K(-42.3%) |
| Sep 2003 | - | -$94.90 K(-280.4%) | -$186.50 K(+21.2%) |
| Jun 2003 | - | $52.60 K(-177.7%) | -$153.90 K(+84.3%) |
| Mar 2003 | - | -$67.70 K(-11.5%) | -$83.50 K(-42.6%) |
| Dec 2002 | -$13.06 M(+17.1%) | -$76.50 K(+22.8%) | -$145.40 K(-36.8%) |
| Sep 2002 | - | -$62.30 K(-150.7%) | -$230.10 K(+7.3%) |
| Jun 2002 | - | $123.00 K(-194.9%) | -$214.50 K(-57.1%) |
| Mar 2002 | - | -$129.60 K(-19.6%) | -$499.70 K(+13.2%) |
| Dec 2001 | -$11.15 M(+32.0%) | -$161.20 K(+245.2%) | -$441.30 K(-19.3%) |
| Sep 2001 | - | -$46.70 K(-71.2%) | -$546.70 K(-4.5%) |
| Jun 2001 | - | -$162.20 K(+127.8%) | -$572.60 K(+19.8%) |
| Mar 2001 | - | -$71.20 K(-73.3%) | -$477.90 K(-12.2%) |
| Dec 2000 | -$8.45 M(+21.0%) | -$266.60 K(+267.2%) | -$544.40 K(-10.8%) |
| Sep 2000 | - | -$72.60 K(+7.6%) | -$610.40 K(+0.7%) |
| Jun 2000 | - | -$67.50 K(-51.0%) | -$605.90 K(-10.1%) |
| Mar 2000 | - | -$137.70 K(-58.6%) | -$674.10 K(+11.8%) |
| Dec 1999 | -$6.98 M(+73.3%) | -$332.60 K(+388.4%) | -$602.70 K(-16.3%) |
| Sep 1999 | - | -$68.10 K(-49.8%) | -$719.80 K(-8.0%) |
| Jun 1999 | - | -$135.70 K(+104.7%) | -$782.70 K(-0.1%) |
| Mar 1999 | - | -$66.30 K(-85.3%) | -$783.10 K(-15.6%) |
| Dec 1998 | -$4.03 M(+260.4%) | -$449.70 K(+243.3%) | -$928.10 K(-58.5%) |
| Sep 1998 | - | -$131.00 K(-3.7%) | -$2.24 M(-29.9%) |
| Jun 1998 | - | -$136.10 K(-35.6%) | -$3.19 M(-28.0%) |
| Mar 1998 | - | -$211.30 K(-88.0%) | -$4.43 M(-18.7%) |
| Dec 1997 | -$1.12 M(-45.3%) | -$1.76 M(+62.0%) | -$5.45 M(+47.6%) |
| Sep 1997 | - | -$1.09 M(-21.1%) | -$3.69 M(+41.6%) |
| Jun 1997 | - | -$1.38 M(+11.7%) | -$2.61 M(+111.7%) |
| Mar 1997 | - | -$1.23 M | -$1.23 M |
| Dec 1996 | -$2.04 M | - | - |
FAQ
- What is COSCIENS Biopharma annual operating income?
- What is the all time high annual operating profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual operating profit year-on-year change?
- What is COSCIENS Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly operating profit year-on-year change?
- What is COSCIENS Biopharma TTM operating income?
- What is the all time high TTM operating profit for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM operating profit year-on-year change?
What is COSCIENS Biopharma annual operating income?
The current annual operating profit of CSCI is -$18.01 M
What is the all time high annual operating profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual operating income is $9.84 M
What is COSCIENS Biopharma annual operating profit year-on-year change?
Over the past year, CSCI annual operating income has changed by -$2.75 M (-18.06%)
What is COSCIENS Biopharma quarterly operating income?
The current quarterly operating profit of CSCI is -$4.83 M
What is the all time high quarterly operating profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly operating income is $2.07 M
What is COSCIENS Biopharma quarterly operating profit year-on-year change?
Over the past year, CSCI quarterly operating income has changed by -$2.71 M (-127.77%)
What is COSCIENS Biopharma TTM operating income?
The current TTM operating profit of CSCI is -$12.52 M
What is the all time high TTM operating profit for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM operating income is $5.53 M
What is COSCIENS Biopharma TTM operating profit year-on-year change?
Over the past year, CSCI TTM operating income has changed by -$7.81 M (-165.60%)